{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:25:32Z","timestamp":1792016732198,"version":"4.4.0"},"reference-count":332,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["E-Rare4\/0003\/2012"],"award-info":[{"award-number":["E-Rare4\/0003\/2012"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/74993\/2010"],"award-info":[{"award-number":["SFRH\/BD\/74993\/2010"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011929","name":"Programa Operacional Tem\u00e1tico Factores de Competitividade","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011929","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.nbd.2016.07.022","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T09:36:13Z","timestamp":1469525773000},"page":"210-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":132,"special_numbering":"C","title":["Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases"],"prefix":"10.1016","volume":"95","author":[{"given":"Joana","family":"Duarte-Neves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Pereira de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8020-9266","authenticated-orcid":false,"given":"Cl\u00e1udia","family":"Cavadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2016.07.022_bb0005","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/306584a0","article-title":"Neuropeptide Y distribution in human brain","volume":"306","author":"Adrian","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2016.07.022_bb0010","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1634\/stemcells.2008-0056","article-title":"Neuropeptide Y promotes neurogenesis in murine subventricular zone","volume":"26","author":"Agasse","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.nbd.2016.07.022_bb0015","author":"Allen Institute for Brain Science"},{"key":"10.1016\/j.nbd.2016.07.022_bb0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0006-8993(85)91632-4","article-title":"Dissociation of neuropeptide Y and somatostatin in Parkinson's disease","volume":"337","author":"Allen","year":"1985","journal-title":"Brain Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb0025","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.6136091","article-title":"Neuropeptide Y distribution in the rat brain","volume":"221","author":"Allen","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.nbd.2016.07.022_bb0030","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1111\/j.1471-4159.2008.05334.x","article-title":"Neuropeptide Y stimulates retinal neural cell proliferation\u2013involvement of nitric oxide","volume":"105","author":"Alvaro","year":"2008","journal-title":"J. Neurochem"},{"key":"10.1016\/j.nbd.2016.07.022_bb0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.neuroscience.2007.12.027","article-title":"Neuropeptide Y protects retinal neural cells against cell death induced by ecstasy","volume":"152","author":"Alvaro","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2016.07.022_bb0040","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.neuint.2007.01.010","article-title":"NPY in rat retina is present in neurons, in endothelial cells and also in microglial and Muller cells","volume":"50","author":"Alvaro","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2016.07.022_bb0045","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/S0028-3908(00)00057-5","article-title":"Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men","volume":"39","author":"Antonijevic","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2016.07.022_bb0050","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1523\/JNEUROSCI.09-12-04333.1989","article-title":"Neuropeptide Y in the cerebral cortex and the caudate-putamen nuclei: ultrastructural basis for interactions with GABAergic and non-GABAergic neurons","volume":"9","author":"Aoki","year":"1989","journal-title":"J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb0055","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1001\/archneur.1988.00520270043019","article-title":"Cerebrospinal fluid somatostatin and neuropeptide Y. Concentrations in aging and in dementia of the Alzheimer type with and without extrapyramidal signs","volume":"45","author":"Atack","year":"1988","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0060","doi-asserted-by":"crossref","first-page":"E1642","DOI":"10.1073\/pnas.1416609112","article-title":"Neuropeptide Y stimulates autophagy in hypothalamic neurons","volume":"112","author":"Aveleira","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.07.022_bb0065","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1007\/s00415-009-0062-8","article-title":"Weight loss in neurodegenerative disorders","volume":"255","author":"Aziz","year":"2008","journal-title":"J. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0070","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S1474-4422(06)70381-7","article-title":"Effect of fetal neural transplants in patients with Huntington's disease 6years after surgery: a long-term follow-up study","volume":"5","author":"Bachoud-Levi","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0075","doi-asserted-by":"crossref","first-page":"9541","DOI":"10.1523\/JNEUROSCI.2891-04.2004","article-title":"Dopamine modulates release from corticostriatal terminals","volume":"24","author":"Bamford","year":"2004","journal-title":"J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb0080","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/j.neuropharm.2012.02.015","article-title":"Neuropeptide Y promotes neurogenesis and protection against methamphetamine-induced toxicity in mouse dentate gyrus-derived neurosphere cultures","volume":"62","author":"Baptista","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2016.07.022_bb0085","doi-asserted-by":"crossref","first-page":"8927","DOI":"10.1523\/JNEUROSCI.17-23-08927.1997","article-title":"Knock-out mice reveal a critical antiepileptic role for neuropeptide Y","volume":"17","author":"Baraban","year":"1997","journal-title":"J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb0090","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0006-8993(01)02999-7","article-title":"Induction of functional and morphological expression of neuropeptide Y (NPY) in cortical cultures by brain-derived neurotrophic factor (BDNF): evidence for a requirement for extracellular-regulated kinase (ERK)-dependent and ERK-independent mechanisms","volume":"919","author":"Barnea","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0006-8993(01)02141-2","article-title":"Interleukin-1beta induces expression of neuropeptide Y in primary astrocyte cultures in a cytokine-specific manner: induction in human but not rat astrocytes","volume":"896","author":"Barnea","year":"2001","journal-title":"Brain Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb0100","series-title":"Huntington's Disease \u2014 Core Concepts and Current Advances","article-title":"BDNF in Huntington's disease: role in pathogenesis and treatment","author":"Baydyuk","year":"2012"},{"key":"10.1016\/j.nbd.2016.07.022_bb0105","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/syn.890020415","article-title":"Somatostatin and neuropeptide Y immunoreactivity in Parkinson's disease dementia with Alzheimer's changes","volume":"2","author":"Beal","year":"1988","journal-title":"Synapse"},{"key":"10.1016\/j.nbd.2016.07.022_bb0110","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid","volume":"321","author":"Beal","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2016.07.022_bb0115","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ana.410200303","article-title":"Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease","volume":"20","author":"Beal","year":"1986","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0120","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/ana.410230606","article-title":"Somatostatin and neuropeptide Y concentrations in pathologically graded cases of Huntington's disease","volume":"23","author":"Beal","year":"1988","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0125","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00221-005-0233-5","article-title":"Chemical characterization of newly generated neurons in the striatum of adult primates","volume":"170","author":"Bedard","year":"2006","journal-title":"Exp. Brain Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb0130","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0092-8674(94)90131-7","article-title":"Hydrogen peroxide mediates amyloid beta protein toxicity","volume":"77","author":"Behl","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2016.07.022_bb0135","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-3-7091-0579-5_14","article-title":"The N-methyl-d-aspartate antagonist memantine retards progression of Huntington's disease","author":"Beister","year":"2004","journal-title":"J. Neural Transm. Suppl."},{"key":"10.1016\/j.nbd.2016.07.022_bb0140","doi-asserted-by":"crossref","first-page":"11464","DOI":"10.1073\/pnas.172403999","article-title":"Newly generated neurons in the amygdala and adjoining cortex of adult primates","volume":"99","author":"Bernier","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.07.022_bb0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1172-6-35","article-title":"Machado-Joseph disease: from first descriptions to new perspectives","volume":"6","author":"Bettencourt","year":"2011","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nbd.2016.07.022_bb0150","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0002-8223(95)00269-3","article-title":"Weight change and body composition in patients with Parkinson's disease","volume":"95","author":"Beyer","year":"1995","journal-title":"J. Am. Diet. Assoc."},{"key":"10.1016\/j.nbd.2016.07.022_bb0155","first-page":"R1030","article-title":"Acute food deprivation and chronic food restriction differentially affect hypothalamic NPY mRNA expression","volume":"285","author":"Bi","year":"2003","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys"},{"key":"10.1016\/j.nbd.2016.07.022_bb0160","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bjorkqvist","year":"2008","journal-title":"J. Exp. Med"},{"key":"10.1016\/j.nbd.2016.07.022_bb0165","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2009.17","article-title":"Linking calorie restriction to longevity through sirtuins and autophagy: any role for TOR","volume":"1","author":"Blagosklonny","year":"2010","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.nbd.2016.07.022_bb0170","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","volume":"8","author":"Block","year":"2007","journal-title":"Nat. Rev. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb0175","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)12192-7","article-title":"Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients","volume":"202","author":"Blum-Degen","year":"1995","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.nbd.2016.07.022_bb0180","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0006-8993(87)90284-8","article-title":"Quinolinic acid does not spare striatal neuropeptide Y-immunoreactive neurons","volume":"415","author":"Boegman","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb0185","doi-asserted-by":"crossref","first-page":"6926","DOI":"10.1523\/JNEUROSCI.0800-08.2008","article-title":"Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease","volume":"28","author":"Boland","year":"2008","journal-title":"J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb0190","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0167-0115(98)00052-4","article-title":"Molecular biology and pharmacology of multiple NPY Y5 receptor species homologs","volume":"75-76","author":"Borowsky","year":"1998","journal-title":"Regul. Pept."},{"key":"10.1016\/j.nbd.2016.07.022_bb0195","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1742-2094-7-81","article-title":"Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures","volume":"7","author":"Bovolenta","year":"2010","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2016.07.022_bb0200","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1159\/000125626","article-title":"Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats","volume":"52","author":"Brady","year":"1990","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.nbd.2016.07.022_bb0205","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.parkreldis.2011.02.004","article-title":"Clinical correlates of olfactory dysfunction in spinocerebellar ataxia type 3","volume":"17","author":"Braga-Neto","year":"2011","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2016.07.022_bb0210","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/neu.480260305","article-title":"The Ca2+ influx induced by beta-amyloid peptide 25-35 in cultured hippocampal neurons results from network excitation","volume":"26","author":"Brorson","year":"1995","journal-title":"J. Neurobiol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0215","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/emmm.201000100","article-title":"Therapeutic potential of neuropeptide Y (NPY) receptor ligands","volume":"2","author":"Brothers","year":"2010","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.nbd.2016.07.022_bb0220","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1212\/01.wnl.0000176061.33817.90","article-title":"Change in body mass index and risk of incident Alzheimer disease","volume":"65","author":"Buchman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2016.07.022_bb0225","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0169-328X(97)00302-1","article-title":"Distribution of a novel hypothalamic neuropeptide Y receptor gene and it's absence in rat","volume":"53","author":"Burkhoff","year":"1998","journal-title":"Brain Res. Mol. Brain Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb0230","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0891-0618(00)00107-1","article-title":"Characterization of NPY mRNA-expressing cells in the human brain: co-localization with Y2 but not Y1 mRNA in the cerebral cortex, hippocampus, amygdala, and striatum","volume":"20","author":"Caberlotto","year":"2000","journal-title":"J. Chem. Neuroanat"},{"key":"10.1016\/j.nbd.2016.07.022_bb0235","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0306-4522(98)00039-6","article-title":"Regional distribution of neuropeptide Y Y2 receptor messenger RNA in the human post mortem brain","volume":"86","author":"Caberlotto","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2016.07.022_bb0240","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1460-9568.1997.tb01476.x","article-title":"Localization of neuropeptide Y Y1 mRNA in the human brain: abundant expression in cerebral cortex and striatum","volume":"9","author":"Caberlotto","year":"1997","journal-title":"Eur. J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb0245","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(01)05625-2","article-title":"In-vivo measurement of activated microglia in dementia","volume":"358","author":"Cagnin","year":"2001","journal-title":"Lancet"},{"issue":"Pt 2","key":"10.1016\/j.nbd.2016.07.022_bb0250","first-page":"433","article-title":"Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease","volume":"116","author":"Calabresi","year":"1993","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2016.07.022_bb0255","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0169-328X(02)00555-7","article-title":"Increased neuropeptide Y mRNA expression in striatum in Parkinson's disease","volume":"110","author":"Cannizzaro","year":"2003","journal-title":"Brain Res. Mol. Brain Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb0260","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1136\/jnnp.40.6.581","article-title":"Biochemical aspects of Huntington's chorea","volume":"40","author":"Caraceni","year":"1977","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2016.07.022_bb0265","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1385\/JMN:28:3:239","article-title":"Emotional behavior in aged neuropeptide Y (NPY) Y2 knockout mice","volume":"28","author":"Carvajal","year":"2006","journal-title":"J. Mol. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb0270","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0006-8993(94)91858-9","article-title":"Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease","volume":"640","author":"Cataldo","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb0275","first-page":"19","article-title":"Depressive symptoms in Machado-Joseph disease (SCA3) patients and their relatives","volume":"10","author":"Cecchin","year":"2007","journal-title":"Community Genet"},{"key":"10.1016\/j.nbd.2016.07.022_bb0280","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/cne.902380404","article-title":"Cortical neurons immunoreactive with antisera against neuropeptide Y are altered in Alzheimer's-type dementia","volume":"238","author":"Chan-Palay","year":"1985","journal-title":"J. Comp. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0285","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/cne.902480307","article-title":"Distribution of altered hippocampal neurons and axons immunoreactive with antisera against neuropeptide Y in Alzheimer's-type dementia","volume":"248","author":"Chan-Palay","year":"1986","journal-title":"J. Comp. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0290","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1055\/s-2003-38093","article-title":"Fluoxetine-induced exacerbation of chorea in Huntington's disease? A case report","volume":"36","author":"Chari","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.nbd.2016.07.022_bb0295","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1600-0404.1998.tb00614.x","article-title":"Cortisol is higher in parkinsonism and associated with gait deficit","volume":"97","author":"Charlett","year":"1998","journal-title":"Acta Neurol. Scand"},{"key":"10.1016\/j.nbd.2016.07.022_bb0300","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ana.10577","article-title":"Weight loss in Parkinson's disease","volume":"53","author":"Chen","year":"2003","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0305","doi-asserted-by":"crossref","first-page":"12713","DOI":"10.1523\/JNEUROSCI.3909-08.2008","article-title":"Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 3","volume":"28","author":"Chen","year":"2008","journal-title":"J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb0310","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.yfrne.2013.05.001","article-title":"Hypothalamic neurogenesis in the adult brain","volume":"34","author":"Cheng","year":"2013","journal-title":"Front. Neuroendocrinol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0315","first-page":"214","article-title":"Dysphagia in Alzheimer disease: a review","volume":"4","author":"Chouinard","year":"2000","journal-title":"J. Nutr. Health Aging"},{"key":"10.1016\/j.nbd.2016.07.022_bb0320","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1046\/j.1460-9568.2002.01938.x","article-title":"Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging","volume":"15","author":"Cicchetti","year":"2002","journal-title":"Eur. J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb0325","doi-asserted-by":"crossref","first-page":"117","DOI":"10.55782\/ane-2003-1461","article-title":"Dynamics of expression of the mRNA for cytokines and inducible nitric synthase in a murine model of the Parkinson's disease","volume":"63","author":"Ciesielska","year":"2003","journal-title":"Acta Neurobiol. Exp. (Wars)"},{"key":"10.1016\/j.nbd.2016.07.022_bb0330","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1210\/endo-115-1-427","article-title":"Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats","volume":"115","author":"Clark","year":"1984","journal-title":"Endocrinology"},{"key":"10.1016\/j.nbd.2016.07.022_bb0335","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nrd4308","article-title":"Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders","volume":"13","author":"Conn","year":"2014","journal-title":"Nat. Rev. Drug Discov"},{"key":"10.1016\/j.nbd.2016.07.022_bb0340","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1471-4159.2012.07770.x","article-title":"The neuroprotective and neurogenic effects of neuropeptide Y administration in an animal model of hippocampal neurodegeneration and temporal lobe epilepsy induced by trimethyltin","volume":"122","author":"Corvino","year":"2012","journal-title":"J. Neurochem"},{"key":"10.1016\/j.nbd.2016.07.022_bb0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088294","article-title":"The neurogenic effects of exogenous neuropeptide Y: early molecular events and long-lasting effects in the hippocampus of trimethyltin-treated rats","volume":"9","author":"Corvino","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2016.07.022_bb0350","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainres.2011.05.033","article-title":"Influence of neuropeptide Y and antidepressants upon cerebral monoamines involved in depression: an in vivo electrochemical study","volume":"1407","author":"Crespi","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb0355","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1021\/cn200127e","article-title":"Neuropeptide Y protects rat cortical neurons against beta-amyloid toxicity and re-establishes synthesis and release of nerve growth factor","volume":"3","author":"Croce","year":"2012","journal-title":"ACS Chem. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb0360","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11010-013-1567-0","article-title":"NPY modulates miR-30a-5p and BDNF in opposite direction in an in vitro model of Alzheimer disease: a possible role in neuroprotection?","volume":"376","author":"Croce","year":"2013","journal-title":"Mol. Cell. Biochem"},{"key":"10.1016\/j.nbd.2016.07.022_bb0365","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jneuroim.2010.09.020","article-title":"Inflammation and gliosis in neurological diseases\u2013clinical implications","volume":"231","author":"Czlonkowska","year":"2011","journal-title":"J. Neuroimmunol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0370","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"Dalrymple","year":"2007","journal-title":"J. Proteome Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb0375","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0022-510X(90)90057-T","article-title":"A quantitative assessment of somatostatin-like and neuropeptide Y-like immunostained cells in the frontal and temporal cortex of patients with Alzheimer's disease","volume":"96","author":"Davies","year":"1990","journal-title":"J. Neurol. Sci"},{"key":"10.1016\/j.nbd.2016.07.022_bb0380","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1176\/ajp.143.3.300","article-title":"Cortisol and Alzheimer's disease, I: basal studies","volume":"143","author":"Davis","year":"1986","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.nbd.2016.07.022_bb0385","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0006-8993(85)90921-7","article-title":"Survival of basal ganglia neuropeptide Y-somatostatin neurones in Huntington's disease","volume":"340","author":"Dawbarn","year":"1985","journal-title":"Brain Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb0390","doi-asserted-by":"crossref","first-page":"7797","DOI":"10.1073\/pnas.88.17.7797","article-title":"Nitric oxide synthase and neuronal NADPH diaphorase are identical in brain and peripheral tissues","volume":"88","author":"Dawson","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.07.022_bb0395","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1083\/jcb.200407053","article-title":"New GABAergic interneurons in the adult neocortex and striatum are generated from different precursors","volume":"168","author":"Dayer","year":"2005","journal-title":"J. Cell Biol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0400","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","article-title":"Epidemiology of Parkinson's disease","volume":"5","author":"de Lau","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0405","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0306-4522(86)90056-4","article-title":"Distribution of neuropeptide Y-like immunoreactivity in the rat central nervous system\u2013I. Radioimmunoassay and chromatographic characterisation","volume":"18","author":"de Quidt","year":"1986","journal-title":"Neuroscince"},{"key":"10.1016\/j.nbd.2016.07.022_bb0410","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.neurobiolaging.2011.06.018","article-title":"Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease","volume":"33","author":"Decressac","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2016.07.022_bb0415","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.nbd.2009.02.017","article-title":"Neuropeptide Y stimulates proliferation, migration and differentiation of neural precursors from the subventricular zone in adult mice","volume":"34","author":"Decressac","year":"2009","journal-title":"Neurobiol. Dis"},{"key":"10.1016\/j.nbd.2016.07.022_bb0420","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/hipo.20765","article-title":"Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis","volume":"21","author":"Decressac","year":"2011","journal-title":"Hippocampus"},{"key":"10.1016\/j.nbd.2016.07.022_bb0425","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.expneurol.2010.07.022","article-title":"Neuropeptide Y modifies the disease course in the R6\/2 transgenic model of Huntington's disease","volume":"226","author":"Decressac","year":"2010","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0430","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0304-3940(95)11384-9","article-title":"Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and beta-amyloid production in cultures","volume":"188","author":"Del Bo","year":"1995","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.nbd.2016.07.022_bb0435","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/mds.1112","article-title":"Intravenous amantadine improves levadopa-induced dyskinesias: an acute double-blind placebo-controlled study","volume":"16","author":"Del Dotto","year":"2001","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2016.07.022_bb0440","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1172\/JCI74664","article-title":"Remote control of induced dopaminergic neurons in parkinsonian rats","volume":"124","author":"Dell'Anno","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2016.07.022_bb0445","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.nbd.2003.08.003","article-title":"Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice overexpressing beta-amyloid precursor protein (APP) with the Swedish double mutation (APP23)","volume":"14","author":"Diez","year":"2003","journal-title":"Neurobiol. Dis"},{"key":"10.1016\/j.nbd.2016.07.022_bb0450","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0306-4522(00)00261-X","article-title":"Neuropeptides in hippocampus and cortex in transgenic mice overexpressing V717F beta-amyloid precursor protein\u2013initial observations","volume":"100","author":"Diez","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2016.07.022_bb0455","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2016.07.022_bb0460","doi-asserted-by":"crossref","first-page":"10562","DOI":"10.1074\/jbc.M205747200","article-title":"Homodimerization of neuropeptide y receptors investigated by fluorescence resonance energy transfer in living cells","volume":"278","author":"Dinger","year":"2003","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.nbd.2016.07.022_bb0465","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1212\/01.WNL.0000031791.10922.CF","article-title":"Weight loss in early stage of Huntington's disease","volume":"59","author":"Djousse","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2016.07.022_bb0470","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/aps.2009.24","article-title":"Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases","volume":"30","author":"Dong","year":"2009","journal-title":"Acta Pharmacol. Sin"},{"key":"10.1016\/j.nbd.2016.07.022_bb0475","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.2174\/1389450111007011281","article-title":"Potential therapeutic targets for neurodegenerative diseases: lessons learned from calorie restriction","volume":"11","author":"Duan","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.nbd.2016.07.022_bb0480","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddv271","article-title":"Neuropeptide Y mitigates neuropathology and motor deficits in mouse models of Machado-Joseph disease","author":"Duarte-Neves","year":"2015","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.nbd.2016.07.022_bb0485","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","article-title":"Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study","volume":"62","author":"Duff","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2016.07.022_bb0490","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/(SICI)1096-9861(19981221)402:3<372::AID-CNE6>3.0.CO;2-2","article-title":"Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, Guinea pig, and primates brains","volume":"402","author":"Dumont","year":"1998","journal-title":"J. Comp. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0495","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4161\/auto.6.2.11139","article-title":"Autophagy: polyQ toxic fragment turnover","volume":"6","author":"Duncan","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.nbd.2016.07.022_bb0500","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/ana.410390411","article-title":"Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features","volume":"39","author":"Durr","year":"1996","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0505","first-page":"167","article-title":"Neuropeptides in cerebrospinal fluid of patients with Alzheimer's disease and dementia with frontotemporal lobe degeneration","volume":"4","author":"Edvinsson","year":"1993","journal-title":"Dementia"},{"key":"10.1016\/j.nbd.2016.07.022_bb0510","doi-asserted-by":"crossref","first-page":"13632","DOI":"10.1073\/pnas.2234031100","article-title":"Inflammation is detrimental for neurogenesis in adult brain","volume":"100","author":"Ekdahl","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.07.022_bb0515","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1474-4422(03)00351-X","article-title":"Dementia associated with Parkinson's disease","volume":"2","author":"Emre","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0520","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0006-8993(92)90716-M","article-title":"Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin","volume":"581","author":"Engber","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb0525","first-page":"272","article-title":"Neuronal intranuclear inclusions, dysregulation of cytokine expression and cell death in spinocerebellar ataxia type 3","volume":"25","author":"Evert","year":"2006","journal-title":"Clin. Neuropathol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0530","doi-asserted-by":"crossref","first-page":"5389","DOI":"10.1523\/JNEUROSCI.21-15-05389.2001","article-title":"Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains","volume":"21","author":"Evert","year":"2001","journal-title":"J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb0535","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/ajpa.1330670304","article-title":"An anthropometric assessment of Huntington's disease patients and families","volume":"67","author":"Farrer","year":"1985","journal-title":"Am. J. Phys. Anthropol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0540","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1471-4159.2011.07541.x","article-title":"Neuropeptide Y inhibits interleukin-1 beta-induced microglia motility","volume":"120","author":"Ferreira","year":"2012","journal-title":"J. Neurochem"},{"key":"10.1016\/j.nbd.2016.07.022_bb0545","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1742-2094-8-169","article-title":"Neuropeptide Y inhibits interleukin-1beta-induced phagocytosis by microglial cells","volume":"8","author":"Ferreira","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nbd.2016.07.022_bb0550","doi-asserted-by":"crossref","first-page":"41921","DOI":"10.1074\/jbc.M110.164020","article-title":"Neuropeptide Y modulation of interleukin-1beta (IL-1b)-induced nitric oxide production in microglia","volume":"285","author":"Ferreira","year":"2010","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.nbd.2016.07.022_bb0555","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(00)02237-X","article-title":"Brain-derived neurotrophic factor in Huntington disease","volume":"866","author":"Ferrer","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb0560","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/exnr.1994.1145","article-title":"Relative survival of striatal projection neurons and interneurons after intrastriatal injection of quinolinic acid in rats","volume":"129","author":"Figueredo-Cardenas","year":"1994","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0565","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1006\/exnr.1997.6549","article-title":"Age-dependent differences in survival of striatal somatostatin-NPY-NADPH-diaphorase-containing interneurons versus striatal projection neurons after intrastriatal injection of quinolinic acid in rats","volume":"146","author":"Figueredo-Cardenas","year":"1997","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0570","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0006-8993(96)00801-3","article-title":"Colocalization of somatostatin, neuropeptide Y, neuronal nitric oxide synthase and NADPH-diaphorase in striatal interneurons in rats","volume":"735","author":"Figueredo-Cardenas","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb0575","first-page":"631","article-title":"Cognitive impairment of Alzheimer disease","volume":"5","author":"Folstein","year":"1983","journal-title":"Neurobehav. Toxicol. Teratol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0580","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF02900219","article-title":"Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission","volume":"247","author":"Frommberger","year":"1997","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb0585","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1523\/JNEUROSCI.21-15-05804.2001","article-title":"Plasticity of Y1 and Y2 receptors and neuropeptide Y fibers in patients with temporal lobe epilepsy","volume":"21","author":"Furtinger","year":"2001","journal-title":"J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb0590","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11481-006-9015-5","article-title":"Microglia biology in health and disease","volume":"1","author":"Garden","year":"2006","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.nbd.2016.07.022_bb0595","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1016\/j.bcp.2007.08.017","article-title":"Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties","volume":"74","author":"Gehlert","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nbd.2016.07.022_bb0600","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0006-3223(98)00292-3","article-title":"Leptin, neuropeptide Y, and peptide YY in long-term recovered eating disorder patients","volume":"46","author":"Gendall","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2016.07.022_bb0605","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/S0014-4886(03)00388-1","article-title":"Relationship between CSF hypocretin levels and hypocretin neuronal loss","volume":"184","author":"Gerashchenko","year":"2003","journal-title":"Exp. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0610","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease","volume":"21","author":"Gerhard","year":"2006","journal-title":"Neurobiol. Dis"},{"key":"10.1016\/j.nbd.2016.07.022_bb0615","doi-asserted-by":"crossref","first-page":"637S","DOI":"10.1093\/ajcn\/71.2.637s","article-title":"Weight loss in Alzheimer disease","volume":"71","author":"Gillette-Guyonnet","year":"2000","journal-title":"Am. J. Clin. Nutr"},{"key":"10.1016\/j.nbd.2016.07.022_bb0620","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the global burden of disease study 2013","author":"Global Burden of Disease Study, C","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2016.07.022_bb0625","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1111\/j.1460-9568.2012.08232.x","article-title":"Protective role of neuropeptide Y Y(2) receptors in cell death and microglial response following methamphetamine injury","volume":"36","author":"Goncalves","year":"2012","journal-title":"Eur. J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb0630","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1002\/ana.23866","article-title":"Caffeine and adenosine A(2A) receptor inactivation decrease striatal neuropathology in a lentiviral-based model of Machado-Joseph disease","volume":"73","author":"Goncalves","year":"2013","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0635","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/jnnp.49.4.381","article-title":"Depression in Parkinson's disease: a quantitative and qualitative analysis","volume":"49","author":"Gotham","year":"1986","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2016.07.022_bb0640","doi-asserted-by":"crossref","first-page":"10910","DOI":"10.1073\/pnas.181354698","article-title":"Adult-generated hippocampal and neocortical neurons in macaques have a transient existence","volume":"98","author":"Gould","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.07.022_bb0645","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0006-8993(95)00669-H","article-title":"Neurodegeneration mediated by glutamate and beta-amyloid peptide: a comparison and possible interaction","volume":"691","author":"Gray","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb0650","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/clinchem\/47.6.1075","article-title":"Disappearance rate of catecholamines, total metanephrines, and neuropeptide Y from the plasma of patients after resection of pheochromocytoma","volume":"47","author":"Grouzmann","year":"2001","journal-title":"Clin. Chem"},{"key":"10.1016\/j.nbd.2016.07.022_bb0655","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.mp.4002075","article-title":"Is it time to reassess the BDNF hypothesis of depression?","volume":"12","author":"Groves","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2016.07.022_bb0660","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/ajcn\/82.2.435","article-title":"Different modes of weight loss in Alzheimer disease: a prospective study of 395 patients","volume":"82","author":"Guerin","year":"2005","journal-title":"Am. J. Clin. Nutr"},{"key":"10.1016\/j.nbd.2016.07.022_bb0665","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/0278-5846(90)90018-C","article-title":"HPA axis responsivity to dexamethasone and cognitive impairment in dementia","volume":"14","author":"Gurevich","year":"1990","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2016.07.022_bb0670","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0169-328X(97)00017-X","article-title":"Distribution of the neuropeptide Y Y2 receptor mRNA in rat central nervous system","volume":"46","author":"Gustafson","year":"1997","journal-title":"Brain Res. Mol. Brain Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb0675","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/35073601","article-title":"Neuropeptide Y functions as a neuroproliferative factor","volume":"410","author":"Hansel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2016.07.022_bb0680","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.0040024.eor","article-title":"A role for autophagy genes in the extension of lifespan by dietary restriction in C. elegans","author":"Hansen","year":"2005","journal-title":"PLoS Genet"},{"key":"10.1016\/j.nbd.2016.07.022_bb0685","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nature04724","article-title":"Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice","volume":"441","author":"Hara","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2016.07.022_bb0690","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1474-4422(03)00350-8","article-title":"Genes and parkinsonism","volume":"2","author":"Hardy","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0695","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1046\/j.1460-9568.2000.00164.x","article-title":"Beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis","volume":"12","author":"Harkany","year":"2000","journal-title":"Eur. J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb0700","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/mds.10379","article-title":"Olfaction in neurodegenerative disorder","volume":"18","author":"Hawkes","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2016.07.022_bb0705","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0006-3223(94)00239-Y","article-title":"Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia","volume":"38","author":"Heilig","year":"1995","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2016.07.022_bb0710","doi-asserted-by":"crossref","first-page":"6526","DOI":"10.1073\/pnas.81.20.6526","article-title":"Neuropeptide-containing neurons of the cerebral cortex are also GABAergic","volume":"81","author":"Hendry","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.07.022_bb0715","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4161\/auto.6.8.13617","article-title":"Early alterations of autophagy in Huntington disease-like mice","volume":"6","author":"Heng","year":"2010","journal-title":"Autophagy"},{"key":"10.1016\/j.nbd.2016.07.022_bb0720","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0006-3223(91)90007-9","article-title":"The limbic-hypothalamic-pituitary-adrenal axis in Huntington's disease","volume":"30","author":"Heuser","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2016.07.022_bb0725","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/archneur.57.6.846","article-title":"Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas","volume":"57","author":"Hock","year":"2000","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0730","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1007\/s00415-011-5992-2","article-title":"Longitudinal study on MRI intensity changes of Machado-Joseph disease: correlation between MRI findings and neuropathological changes","volume":"258","author":"Horimoto","year":"2011","journal-title":"J. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0735","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/0006-2952(75)90190-2","article-title":"Parkinson's disease and its chemotherapy","volume":"24","author":"Hornykiewicz","year":"1975","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.nbd.2016.07.022_bb0740","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1471-4159.2003.01895.x","article-title":"Neuropeptide Y is neuroproliferative for post-natal hippocampal precursor cells","volume":"86","author":"Howell","year":"2003","journal-title":"J. Neurochem"},{"key":"10.1016\/j.nbd.2016.07.022_bb0745","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","article-title":"Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial","volume":"66","author":"Huntington Study, G","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2016.07.022_bb0750","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00455-013-9450-4","article-title":"Differences in dysphagia between spinocerebellar ataxia type 3 and type 6","volume":"28","author":"Isono","year":"2013","journal-title":"Dysphagia"},{"key":"10.1016\/j.nbd.2016.07.022_bb0755","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011102","article-title":"Regulation of amyloid precursor protein processing by the beclin 1 complex","volume":"5","author":"Jaeger","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2016.07.022_bb0760","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF03159935","article-title":"Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway","volume":"14","author":"Jellinger","year":"1991","journal-title":"Mol. Chem. Neuropathol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0765","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1001\/archneur.63.9.1312","article-title":"Accelerated weight loss may precede diagnosis in Alzheimer disease","volume":"63","author":"Johnson","year":"2006","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0770","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF02493441","article-title":"Dysphagia in Huntington's disease: a 16-year retrospective","volume":"7","author":"Kagel","year":"1992","journal-title":"Dysphagia"},{"key":"10.1016\/j.nbd.2016.07.022_bb0775","doi-asserted-by":"crossref","first-page":"10931","DOI":"10.1073\/pnas.88.23.10931","article-title":"Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food","volume":"88","author":"Kalra","year":"1991","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.07.022_bb0780","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1210\/endo.141.3.7387","article-title":"Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice","volume":"141","author":"Kanatani","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.nbd.2016.07.022_bb0785","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0149-7634(01)00066-5","article-title":"The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y","volume":"26","author":"Kask","year":"2002","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nbd.2016.07.022_bb0790","first-page":"E479","article-title":"Nonsaturable entry of neuropeptide Y into brain","volume":"276","author":"Kastin","year":"1999","journal-title":"Am. J. Phys"},{"key":"10.1016\/j.nbd.2016.07.022_bb0795","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/ng1194-221","article-title":"CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1","volume":"8","author":"Kawaguchi","year":"1994","journal-title":"Nat. Genet"},{"key":"10.1016\/j.nbd.2016.07.022_bb0800","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/archpsyc.1990.01810180048008","article-title":"Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa","volume":"47","author":"Kaye","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.nbd.2016.07.022_bb0805","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0304-3940(86)90174-6","article-title":"Striatal neuropeptide Y neurones are under the influence of the nigrostriatal dopaminergic pathway: immunohistochemical evidence","volume":"66","author":"Kerkerian","year":"1986","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.nbd.2016.07.022_bb0810","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0306-4522(88)90101-7","article-title":"Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons","volume":"26","author":"Kerkerian","year":"1988","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2016.07.022_bb0815","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.genhosppsych.2007.11.005","article-title":"Behavioural problems in Huntington's disease using the problem behaviours assessment","volume":"30","author":"Kingma","year":"2008","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.nbd.2016.07.022_bb0820","first-page":"120","article-title":"Preferential loss of serotonin markers in caudate versus putamen in Parkinson's disease","volume":"131","author":"Kish","year":"2008","journal-title":"Brain"},{"issue":"Pt 9","key":"10.1016\/j.nbd.2016.07.022_bb0825","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/brain\/121.9.1687","article-title":"Autosomal dominant cerebellar ataxia type I. MRI-based volumetry of posterior fossa structures and basal ganglia in spinocerebellar ataxia types 1, 2 and 3","volume":"121","author":"Klockgether","year":"1998","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2016.07.022_bb0830","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00109-013-1092-3","article-title":"Association of age at onset in Huntington disease with functional promoter variations in NPY and NPY2R","volume":"92","author":"Kloster","year":"2014","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.nbd.2016.07.022_bb0835","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature10671","article-title":"Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease","volume":"480","author":"Koch","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2016.07.022_bb0840","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0304-3940(95)11973-Z","article-title":"Plasma neuropeptide Y is reduced in patients with Alzheimer's disease","volume":"198","author":"Koide","year":"1995","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.nbd.2016.07.022_bb0845","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/cne.21492","article-title":"Evidence for constitutive neural cell proliferation in the adult murine hypothalamus","volume":"505","author":"Kokoeva","year":"2007","journal-title":"J. Comp. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0850","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nature04723","article-title":"Loss of autophagy in the central nervous system causes neurodegeneration in mice","volume":"441","author":"Komatsu","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2016.07.022_bb0855","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12311-013-0516-5","article-title":"Mutant ataxin-3 with an abnormally expanded polyglutamine chain disrupts dendritic development and metabotropic glutamate receptor signaling in mouse cerebellar Purkinje cells","volume":"13","author":"Konno","year":"2014","journal-title":"Cerebellum"},{"issue":"Suppl. 16","key":"10.1016\/j.nbd.2016.07.022_bb0860","first-page":"18","article-title":"Clinical features of treatment-resistant depression","volume":"62","author":"Kornstein","year":"2001","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.nbd.2016.07.022_bb0865","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/0306-4522(87)90242-9","article-title":"Neuropeptide Y, somatostatin, and reduced nicotinamide adenine dinucleotide phosphate diaphorase in the human striatum: a combined immunocytochemical and enzyme histochemical study","volume":"20","author":"Kowall","year":"1987","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2016.07.022_bb0870","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.neures.2004.01.011","article-title":"Characterization of striatal cultures with the effect of QUIN and NMDA","volume":"49","author":"Kumar","year":"2004","journal-title":"Neurosci. Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb0875","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/1531-8257(200003)15:2<216::AID-MDS1003>3.0.CO;2-#","article-title":"The quality of life in Parkinson's disease","volume":"15","author":"Kuopio","year":"2000","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2016.07.022_bb0880","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1111\/j.1476-5381.1996.tb15647.x","article-title":"Intranasal administration of neuropeptide Y in man: systemic absorption and functional effects","volume":"118","author":"Lacroix","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.nbd.2016.07.022_bb0885","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0167-0115(95)00169-7","article-title":"Evolution of neuropeptide Y, peptide YY and pancreatic polypeptide","volume":"62","author":"Larhammar","year":"1996","journal-title":"Regul. Pept."},{"key":"10.1016\/j.nbd.2016.07.022_bb0890","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0196-9781(01)00331-X","article-title":"Origins of the many NPY-family receptors in mammals","volume":"22","author":"Larhammar","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.nbd.2016.07.022_bb0895","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00424-010-0809-1","article-title":"Glutamate receptors, neurotoxicity and neurodegeneration","volume":"460","author":"Lau","year":"2010","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.nbd.2016.07.022_bb0900","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1210\/en.2014-1192","article-title":"Early intervention with intranasal NPY prevents single prolonged stress-triggered impairments in hypothalamus and ventral hippocampus in male rats","volume":"155","author":"Laukova","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.nbd.2016.07.022_bb0905","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0196-9781(84)90165-7","article-title":"Neuropeptide Y: a potent inducer of consummatory behavior in rats","volume":"5","author":"Levine","year":"1984","journal-title":"Peptides"},{"key":"10.1016\/j.nbd.2016.07.022_bb0910","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F","article-title":"Enhanced sensitivity to N-methyl-d-aspartate receptor activation in transgenic and knockin mouse models of Huntington's disease","volume":"58","author":"Levine","year":"1999","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb0915","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.npep.2004.05.005","article-title":"NPY and Y receptors: lessons from transgenic and knockout models","volume":"38","author":"Lin","year":"2004","journal-title":"Neuropeptides"},{"issue":"Suppl. 2","key":"10.1016\/j.nbd.2016.07.022_bb0920","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1007\/s100720200081","article-title":"Amantadine in Huntington's disease: open-label video-blinded study","volume":"23","author":"Lucetti","year":"2002","journal-title":"Neurol. Sci"},{"key":"10.1016\/j.nbd.2016.07.022_bb0925","doi-asserted-by":"crossref","first-page":"29123","DOI":"10.1074\/jbc.270.49.29123","article-title":"Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY","volume":"270","author":"Lundell","year":"1995","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.nbd.2016.07.022_bb0930","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1523\/JNEUROSCI.4371-05.2006","article-title":"Neurogenesis in the caudate nucleus of the adult rabbit","volume":"26","author":"Luzzati","year":"2006","journal-title":"J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb0935","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/mds.10630","article-title":"Parkinson's disease patients with bilateral subthalamic deep brain stimulation gain weight","volume":"19","author":"Macia","year":"2004","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2016.07.022_bb0940","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/archneur.58.11.1821","article-title":"Improvement in the molecular diagnosis of Machado-Joseph disease","volume":"58","author":"Maciel","year":"2001","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0945","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025416","article-title":"Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits","volume":"6","author":"Majumder","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2016.07.022_bb0950","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF00230496","article-title":"The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy","volume":"85","author":"Mann","year":"1993","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0955","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0006-8993(90)90082-M","article-title":"Neuropeptide Y receptor binding sites in human brain. Possible alteration in Alzheimer's disease","volume":"519","author":"Martel","year":"1990","journal-title":"Brain Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb0960","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF02260903","article-title":"Cerebrospinal fluid norepinephrine, 3-methoxy-4-hydroxyphenylglycol and neuropeptide Y levels in Parkinson's disease, multiple system atrophy and dementia of the Alzheimer type","volume":"4","author":"Martignoni","year":"1992","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect"},{"key":"10.1016\/j.nbd.2016.07.022_bb0965","doi-asserted-by":"crossref","first-page":"27217","DOI":"10.1074\/jbc.271.44.27217","article-title":"Inactivation of a novel neuropeptide Y\/peptide YY receptor gene in primate species","volume":"271","author":"Matsumoto","year":"1996","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.nbd.2016.07.022_bb0970","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1523\/JNEUROSCI.12-02-00376.1992","article-title":"Beta-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity","volume":"12","author":"Mattson","year":"1992","journal-title":"J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb0975","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ana.410410418","article-title":"Cortical peptide changes in Huntington's disease may be independent of striatal degeneration","volume":"41","author":"Mazurek","year":"1997","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb0980","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0006-8993(89)90297-7","article-title":"Coexistence of somatostatin with neuropeptide Y, but not with cholecystokinin or vasoactive intestinal peptide, in neurons of the rat amygdala","volume":"500","author":"McDonald","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb0985","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/0306-4522(94)00629-J","article-title":"Neuropeptide Y and somatostatin-like immunoreactivity in neurons of the monkey amygdala","volume":"66","author":"McDonald","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2016.07.022_bb0990","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0304-3940(89)90659-9","article-title":"Coexistence of GABA and peptide immunoreactivity in non-pyramidal neurons of the basolateral amygdala","volume":"100","author":"McDonald","year":"1989","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.nbd.2016.07.022_bb0995","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0006-3223(03)00530-4","article-title":"Prevalence, etiology, and treatment of depression in Parkinson's disease","volume":"54","author":"McDonald","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2016.07.022_bb1000","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.neurobiolaging.2006.03.013","article-title":"NSAIDs and Alzheimer disease: epidemiological, animal model and clinical studies","volume":"28","author":"McGeer","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2016.07.022_bb1005","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2016.07.022_bb1010","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1093\/hmg\/ddn201","article-title":"A set of differentially expressed miRNAs, including miR-30a-5p, act as post-transcriptional inhibitors of BDNF in prefrontal cortex","volume":"17","author":"Mellios","year":"2008","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.nbd.2016.07.022_bb1015","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/brain\/awu352","article-title":"Transplantation of cerebellar neural stem cells improves motor coordination and neuropathology in Machado-Joseph disease mice","volume":"138","author":"Mendonca","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2016.07.022_bb1020","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/brain\/awp292","article-title":"Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3","volume":"133","author":"Menzies","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2016.07.022_bb1025","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.yfrne.2011.06.001","article-title":"The role of NPY in hypothalamic mediated food intake","volume":"32","author":"Mercer","year":"2011","journal-title":"Front. Neuroendocrinol"},{"key":"10.1016\/j.nbd.2016.07.022_bb1030","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0031-6997(24)01352-8","article-title":"XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors","volume":"50","author":"Michel","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.nbd.2016.07.022_bb1035","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0006-8993(02)03731-9","article-title":"Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40)","volume":"958","author":"Miguel-Hidalgo","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb1040","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.neuro.28.051804.101459","article-title":"Adult neurogenesis in the mammalian central nervous system","volume":"28","author":"Ming","year":"2005","journal-title":"Annu. Rev. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb1045","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.mce.2008.10.044","article-title":"Hungry for life: how the arcuate nucleus and neuropeptide Y may play a critical role in mediating the benefits of calorie restriction","volume":"299","author":"Minor","year":"2009","journal-title":"Mol. Cell. Endocrinol"},{"key":"10.1016\/j.nbd.2016.07.022_bb1050","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.278.5337.412","article-title":"Life and death of neurons in the aging brain","volume":"278","author":"Morrison","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nbd.2016.07.022_bb1055","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/archneur.1991.00530200036015","article-title":"Factors associated with slow progression in Huntington's disease","volume":"48","author":"Myers","year":"1991","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb1060","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jneuroim.2005.09.012","article-title":"Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation","volume":"171","author":"Nair","year":"2006","journal-title":"J. Neuroimmunol"},{"key":"10.1016\/j.nbd.2016.07.022_bb1065","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1093\/brain\/awt144","article-title":"Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado-Joseph disease","volume":"136","author":"Nascimento-Ferreira","year":"2013","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2016.07.022_bb1070","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/brain\/awr047","article-title":"Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease","volume":"134","author":"Nascimento-Ferreira","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2016.07.022_bb1075","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0306-4522(98)00141-9","article-title":"Complementary and overlapping expression of Y1, Y2 and Y5 receptors in the developing and adult mouse nervous system","volume":"87","author":"Naveilhan","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2016.07.022_bb1080","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1471-4159.1993.tb03216.x","article-title":"Regulation of neuropeptide expression in cultured cerebral cortical neurons by brain-derived neurotrophic factor","volume":"60","author":"Nawa","year":"1993","journal-title":"J. Neurochem"},{"key":"10.1016\/j.nbd.2016.07.022_bb1090","series-title":"ClnicalTrials.gov, 2005 March 12","article-title":"Murrough and Mount Sinai School of Medicine, A dose escalation study of intranasal neuropeptide Y in post traumatic stress disorder (PTSD)","author":"NCT01533519","year":"2012"},{"key":"10.1016\/j.nbd.2016.07.022_bb1085","series-title":"Charney, D. and Mount Sinai School of Medicine, Intranasal administration of neuropeptide Y in healthy male volunteers (NPY). ClinicalTrials.gov, 2015 March 26 Internet] Cited","author":"NCT01533519","year":"2015"},{"key":"10.1016\/j.nbd.2016.07.022_bb1095","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0306-4522(02)00256-7","article-title":"The neuropeptide Y receptors, Y1 and Y2, are transiently and differentially expressed in the developing cerebellum","volume":"113","author":"Neveu","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2016.07.022_bb1100","doi-asserted-by":"crossref","first-page":"10295","DOI":"10.1523\/JNEUROSCI.19-23-10295.1999","article-title":"Conservation of expression of neuropeptide Y5 receptor between human and rat hypothalamus and limbic regions suggests an integral role in central neuroendocrine control","volume":"19","author":"Nichol","year":"1999","journal-title":"J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb1105","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0196-9781(01)00571-X","article-title":"Processing of neuropeptide Y, galanin, and somatostatin in the cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia","volume":"22","author":"Nilsson","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.nbd.2016.07.022_bb1110","doi-asserted-by":"crossref","first-page":"3434","DOI":"10.2174\/138161211798072472","article-title":"Gene therapy for Parkinson's and Alzheimer's diseases: from the bench to clinical trials","volume":"17","author":"Nobre","year":"2011","journal-title":"Curr. Pharm. Des"},{"key":"10.1016\/j.nbd.2016.07.022_bb1115","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/gt.2010.23","article-title":"Anticonvulsant effects and behavioural outcomes of rAAV serotype 1 vector-mediated neuropeptide Y overexpression in rat hippocampus","volume":"17","author":"Noe","year":"2010","journal-title":"Gene Ther"},{"key":"10.1016\/j.nbd.2016.07.022_bb1120","series-title":"Jasper's Basic Mechanisms of the Epilepsies, Bethesda (MD)","article-title":"Gene therapy of focal onset epilepsy using adeno-associated virus vector-mediated overexpression of neuropeptide Y","author":"Noe","year":"2012"},{"key":"10.1016\/j.nbd.2016.07.022_bb1125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1460-9568.2007.05631.x","article-title":"Expression patterns of promoters for NPY Y(1) and Y(5) receptors in Y(5)RitTA and Y(1)RVenus BAC-transgenic mice","volume":"26","author":"Oberto","year":"2007","journal-title":"Eur. J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb1130","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00702-003-0047-1","article-title":"Increased striatal neuropeptide Y immunoreactivity and its modulation by deprenyl, clonidine and L-dopa in MPTP-treated mice","volume":"110","author":"Obuchowicz","year":"2003","journal-title":"J. Neural Transm"},{"key":"10.1016\/j.nbd.2016.07.022_bb1135","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.neubiorev.2004.08.006","article-title":"Does neuropeptide Y (NPY) mediate the effects of psychotropic drugs?","volume":"28","author":"Obuchowicz","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.nbd.2016.07.022_bb1140","series-title":"Kainic Acid as a Tool in Neurobiology","first-page":"95","article-title":"Neurotoxicity of excitatory amino acids","year":"1978"},{"key":"10.1016\/j.nbd.2016.07.022_bb5100","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0006-8993(88)90774-3","article-title":"Neuropeptide Y-like immunoreactive neurons in the human olfactory bulb","volume":"451","author":"Ohm","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2016.07.022_bb1145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1034\/j.1600-0404.2000.101002079.x","article-title":"Weight gain following unilateral pallidotomy in Parkinson's disease","volume":"101","author":"Ondo","year":"2000","journal-title":"Acta Neurol. Scand"},{"key":"10.1016\/j.nbd.2016.07.022_bb1150","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.20338","article-title":"Microglial activation and dopamine terminal loss in early Parkinson's disease","volume":"57","author":"Ouchi","year":"2005","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb1155","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.neuropharm.2008.05.004","article-title":"Implication of neuropeptide-Y Y2 receptors in the effects of immune stress on emotional, locomotor and social behavior of mice","volume":"55","author":"Painsipp","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.nbd.2016.07.022_bb1160","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1601-183X.2008.00389.x","article-title":"Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice","volume":"7","author":"Painsipp","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.nbd.2016.07.022_bb1165","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.nbd.2008.06.003","article-title":"Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement","volume":"32","author":"Pan","year":"2008","journal-title":"Neurobiol. Dis"},{"key":"10.1016\/j.nbd.2016.07.022_bb1170","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-2007-971172","article-title":"Dominantly inherited ataxias: lessons learned from Machado-Joseph disease\/spinocerebellar ataxia type 3","volume":"27","author":"Paulson","year":"2007","journal-title":"Semin. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb1175","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0896-6273(00)80943-5","article-title":"Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3","volume":"19","author":"Paulson","year":"1997","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2016.07.022_bb1180","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","article-title":"Microglial activation correlates with severity in Huntington disease: a clinical and PET study","volume":"66","author":"Pavese","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2016.07.022_bb1185","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nm0698-722","article-title":"Cardiovascular response, feeding behavior and locomotor activity in mice lacking the NPY Y1 receptor","volume":"4","author":"Pedrazzini","year":"1998","journal-title":"Nat. Med"},{"key":"10.1016\/j.nbd.2016.07.022_bb1190","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(03)00307-7","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"2","author":"Pfeiffer","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb1195","first-page":"2190","article-title":"The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice","volume":"118","author":"Pickford","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2016.07.022_bb1200","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbi.2005.05.004","article-title":"Dissociation of inflammatory markers and natural killer cell activity in major depressive disorder","volume":"20","author":"Pike","year":"2006","journal-title":"Brain Behav. Immun"},{"key":"10.1016\/j.nbd.2016.07.022_bb1205","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1093\/brain\/awn244","article-title":"Hypothalamic involvement in Huntington's disease: an in vivo PET study","volume":"131","author":"Politis","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2016.07.022_bb1210","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/09513590500519385","article-title":"Plasma levels of neuropeptides in Alzheimer's disease","volume":"22","author":"Proto","year":"2006","journal-title":"Gynecol. Endocrinol"},{"key":"10.1016\/j.nbd.2016.07.022_bb1215","doi-asserted-by":"crossref","first-page":"8169","DOI":"10.1523\/JNEUROSCI.17-21-08169.1997","article-title":"Inhibition of synaptic transmission by neuropeptide Y in rat hippocampal area CA1: modulation of presynaptic Ca2+ entry","volume":"17","author":"Qian","year":"1997","journal-title":"J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb1220","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1046\/j.1471-4159.2002.01210.x","article-title":"Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species","volume":"83","author":"Qin","year":"2002","journal-title":"J. Neurochem"},{"key":"10.1016\/j.nbd.2016.07.022_bb1225","doi-asserted-by":"crossref","first-page":"111","DOI":"10.31887\/DCNS.2009.11.2\/cqiu","article-title":"Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention","volume":"11","author":"Qiu","year":"2009","journal-title":"Dialogues Clin. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb1230","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF02260076","article-title":"Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease","volume":"4","author":"Rabey","year":"1992","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect"},{"key":"10.1016\/j.nbd.2016.07.022_bb1235","doi-asserted-by":"crossref","first-page":"13815","DOI":"10.1523\/JNEUROSCI.5361-07.2008","article-title":"Trafficking and fusion of neuropeptide Y-containing dense-core granules in astrocytes","volume":"28","author":"Ramamoorthy","year":"2008","journal-title":"J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb1240","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.neurobiolaging.2005.09.022","article-title":"Early neuropathology of somatostatin\/NPY GABAergic cells in the hippocampus of a PS1xAPP transgenic model of Alzheimer's disease","volume":"27","author":"Ramos","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2016.07.022_bb1245","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng1362","article-title":"Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease","volume":"36","author":"Ravikumar","year":"2004","journal-title":"Nat. Genet"},{"key":"10.1016\/j.nbd.2016.07.022_bb1250","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.peptides.2005.03.029","article-title":"Role of serotonin (5-HT) in the antidepressant-like properties of neuropeptide Y (NPY) in the mouse forced swim test","volume":"26","author":"Redrobe","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.nbd.2016.07.022_bb1255","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0893-133X(01)00403-1","article-title":"The neuropeptide Y (NPY) Y1 receptor subtype mediates NPY-induced antidepressant-like activity in the mouse forced swimming test","volume":"26","author":"Redrobe","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2016.07.022_bb1260","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1460-9568.2000.00941.x","article-title":"Overexpression of neuropeptide Y induced by brain-derived neurotrophic factor in the rat hippocampus is long lasting","volume":"12","author":"Reibel","year":"2000","journal-title":"Eur. J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb1265","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/jnr.490270419","article-title":"Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy","volume":"27","author":"Reinikainen","year":"1990","journal-title":"J. Neurosci. Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb1270","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2016.07.022_bb1275","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.brainres.2010.11.020","article-title":"Up-regulation of the isoenzymes MAO-A and MAO-B in the human basal ganglia and pons in Huntington's disease revealed by quantitative enzyme radioautography","volume":"1370","author":"Richards","year":"2011","journal-title":"Brain Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb1280","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s12311-008-0013-4","article-title":"SCA3: neurological features, pathogenesis and animal models","volume":"7","author":"Riess","year":"2008","journal-title":"Cerebellum"},{"key":"10.1016\/j.nbd.2016.07.022_bb1285","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2990.2006.00772.x","article-title":"Degeneration of ingestion-related brainstem nuclei in spinocerebellar ataxia type 2, 3, 6 and 7","volume":"32","author":"Rub","year":"2006","journal-title":"Neuropathol. Appl. Neurobiol"},{"key":"10.1016\/j.nbd.2016.07.022_bb1290","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/mp.2012.101","article-title":"Neuropeptide Y and posttraumatic stress disorder","volume":"18","author":"Sah","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.nbd.2016.07.022_bb1295","doi-asserted-by":"crossref","first-page":"8938","DOI":"10.1073\/pnas.132043299","article-title":"Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice","volume":"99","author":"Sainsbury","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.07.022_bb1300","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1101\/gad.979102","article-title":"Y4 receptor knockout rescues fertility in ob\/ob mice","volume":"16","author":"Sainsbury","year":"2002","journal-title":"Genes Dev"},{"key":"10.1016\/j.nbd.2016.07.022_bb1305","doi-asserted-by":"crossref","first-page":"407","DOI":"10.5694\/j.1326-5377.1981.tb135681.x","article-title":"Body weight and dietary factors in Huntington's disease patients compared with matched controls","volume":"1","author":"Sanberg","year":"1981","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.nbd.2016.07.022_bb1310","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.160","article-title":"Neuropeptide Y receptors activation protects rat retinal neural cells against necrotic and apoptotic cell death induced by glutamate","volume":"4","author":"Santos-Carvalho","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.nbd.2016.07.022_bb1315","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s12311-011-0326-6","article-title":"Body mass index is inversely correlated with the expanded CAG repeat length in SCA3\/MJD patients","volume":"11","author":"Saute","year":"2012","journal-title":"Cerebellum"},{"key":"10.1016\/j.nbd.2016.07.022_bb1320","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1750-3639.1998.tb00193.x","article-title":"An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients","volume":"8","author":"Schmidt","year":"1998","journal-title":"Brain Pathol"},{"key":"10.1016\/j.nbd.2016.07.022_bb1325","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00198955","article-title":"Distribution of neuropeptide Y in the prosencephalon of man and cotton-head tamarin (Saguinus oedipus): colocalization with somatostatin in neurons of striatum and amygdala","volume":"181","author":"Schwartzberg","year":"1990","journal-title":"Anat. Embryol. (Berl.)"},{"key":"10.1016\/j.nbd.2016.07.022_bb1330","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-0173(96)00005-7","article-title":"Neuropeptides-immunoreactivity and their mRNA expression in kindling: functional implications for limbic epileptogenesis","volume":"22","author":"Schwarzer","year":"1996","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.nbd.2016.07.022_bb1335","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.neuroscience.2013.01.040","article-title":"Single intranasal neuropeptide Y infusion attenuates development of PTSD-like symptoms to traumatic stress in rats","volume":"236","author":"Serova","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2016.07.022_bb1340","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1093\/hmg\/ddm213","article-title":"Polyglutamine diseases: emerging concepts in pathogenesis and therapy","author":"Shao","year":"2007","journal-title":"Hum. Mol. Genet"},{"key":"10.1016\/j.nbd.2016.07.022_bb1345","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1124\/mol.51.4.597","article-title":"Neuropeptide Y treatment and food deprivation increase cyclic AMP response element-binding in rat hypothalamus","volume":"51","author":"Sheriff","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.nbd.2016.07.022_bb1350","doi-asserted-by":"crossref","first-page":"14474","DOI":"10.1074\/jbc.M600364200","article-title":"Regulation of intracellular accumulation of mutant Huntingtin by beclin 1","volume":"281","author":"Shibata","year":"2006","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.nbd.2016.07.022_bb1355","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.psyneuen.2012.10.020","article-title":"Cortisol and depression in pre-diagnosed and early stage Huntington's disease","volume":"38","author":"Shirbin","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.nbd.2016.07.022_bb1360","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.nbd.2010.05.021","article-title":"Motor uncoordination and neuropathology in a transgenic mouse model of Machado-Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products","volume":"40","author":"Silva-Fernandes","year":"2010","journal-title":"Neurobiol. Dis"},{"key":"10.1016\/j.nbd.2016.07.022_bb1365","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1096\/fj.02-0885fje","article-title":"Activation of neuropeptide Y receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures","volume":"17","author":"Silva","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.nbd.2016.07.022_bb1370","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2174\/1568007054546153","article-title":"The putative neuroprotective role of neuropeptide Y in the central nervous system","volume":"4","author":"Silva","year":"2005","journal-title":"Curr. Drug Targets CNS Neurol. Disord."},{"key":"10.1016\/j.nbd.2016.07.022_bb1375","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/brain\/aws177","article-title":"Calpastatin-mediated inhibition of calpains in the mouse brain prevents mutant ataxin 3 proteolysis, nuclear localization and aggregation, relieving Machado-Joseph disease","volume":"135","author":"Simoes","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2016.07.022_bb1380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157146","article-title":"Discovery of small-molecule modulators of the human Y4 receptor","volume":"11","author":"Sliwoski","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2016.07.022_bb1385","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.npep.2009.02.002","article-title":"Neuroprotective effects of neuropeptide Y-Y2 and Y5 receptor agonists in vitro and in vivo","volume":"43","author":"Smialowska","year":"2009","journal-title":"Neuropeptides"},{"key":"10.1016\/j.nbd.2016.07.022_bb1390","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0006-8993(86)91131-5","article-title":"Neuropeptide Y-immunoreactive neurons in the striatum of cat and monkey: morphological characteristics, intrinsic organization and co-localization with somatostatin","volume":"372","author":"Smith","year":"1986","journal-title":"Brain Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb1395","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3233\/JAD-2011-110713","article-title":"Weight loss and rapid cognitive decline in community-dwelling patients with Alzheimer's disease","volume":"28","author":"Soto","year":"2012","journal-title":"J. Alzheimers Dis"},{"key":"10.1016\/j.nbd.2016.07.022_bb1400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022333","article-title":"Moderate long-term modulation of neuropeptide Y in hypothalamic arcuate nucleus induces energy balance alterations in adult rats","volume":"6","author":"Sousa-Ferreira","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2016.07.022_bb1405","doi-asserted-by":"crossref","first-page":"13578","DOI":"10.1523\/JNEUROSCI.4390-09.2009","article-title":"Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson's and Lewy body diseases","volume":"29","author":"Spencer","year":"2009","journal-title":"J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb1410","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009979","article-title":"Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease","volume":"5","author":"Spilman","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2016.07.022_bb1415","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/cne.21046","article-title":"Characterization of neuropeptide Y2 receptor protein expression in the mouse brain. I. Distribution in cell bodies and nerve terminals","volume":"499","author":"Stanic","year":"2006","journal-title":"J. Comp. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb1420","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/cne.22608","article-title":"Characterization of NPY Y2 receptor protein expression in the mouse brain. II. Coexistence with NPY, the Y1 receptor, and other neurotransmitter-related molecules","volume":"519","author":"Stanic","year":"2011","journal-title":"J. Comp. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb1425","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1073\/pnas.82.11.3940","article-title":"Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior","volume":"82","author":"Stanley","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.07.022_bb1430","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1006\/bbrc.2000.3656","article-title":"Neuropeptide Y receptor gene y6: multiple deaths or resurrections?","volume":"277","author":"Starback","year":"2000","journal-title":"Biochem. Biophys. Res. Commun"},{"key":"10.1016\/j.nbd.2016.07.022_bb1435","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1176\/appi.ajp.162.11.2086","article-title":"The construct of minor and major depression in Alzheimer's disease","volume":"162","author":"Starkstein","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.nbd.2016.07.022_bb1440","doi-asserted-by":"crossref","first-page":"R9","DOI":"10.1016\/S0014-2999(99)00800-6","article-title":"Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats","volume":"387","author":"Stogner","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2016.07.022_bb1445","first-page":"17","article-title":"Machado-Joseph disease","volume":"3","author":"Sudarsky","year":"1995","journal-title":"Clin. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb1450","doi-asserted-by":"crossref","first-page":"24713","DOI":"10.1074\/jbc.M103501200","article-title":"Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-d-aspartate receptors via post-synaptic density 95","volume":"276","author":"Sun","year":"2001","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.nbd.2016.07.022_bb1455","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0006-3223(91)90073-U","article-title":"Reduced cerebrospinal fluid dynorphin A1-8 in Alzheimer's disease","volume":"30","author":"Sunderland","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2016.07.022_bb1460","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.tins.2007.03.008","article-title":"D1 and D2 dopamine-receptor modulation of striatal glutamatergic signaling in striatal medium spiny neurons","volume":"30","author":"Surmeier","year":"2007","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb1465","first-page":"R1020","article-title":"Hypothalamic NPY, AGRP, and POMC mRNA responses to leptin and refeeding in mice","volume":"283","author":"Swart","year":"2002","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys"},{"key":"10.1016\/j.nbd.2016.07.022_bb1470","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington's disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2016.07.022_bb1475","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1073\/pnas.0409402102","article-title":"Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease","volume":"102","author":"Tang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.07.022_bb1480","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0896-6273(00)81010-7","article-title":"Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism","volume":"20","author":"Tao","year":"1998","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2016.07.022_bb1485","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.neuroscience.2008.11.048","article-title":"Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice","volume":"158","author":"Tasan","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2016.07.022_bb1490","doi-asserted-by":"crossref","first-page":"5485","DOI":"10.1073\/pnas.79.18.5485","article-title":"Neuropeptide Y: complete amino acid sequence of the brain peptide","volume":"79","author":"Tatemoto","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.07.022_bb1495","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/296659a0","article-title":"Neuropeptide Y\u2014a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide","volume":"296","author":"Tatemoto","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2016.07.022_bb1500","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0304-3940(01)01592-0","article-title":"Early induction of interleukin-6 mRNA in the hippocampus and cortex of APPsw transgenic mice Tg2576","volume":"301","author":"Tehranian","year":"2001","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.nbd.2016.07.022_bb1505","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2016.07.022_bb1510","doi-asserted-by":"crossref","first-page":"5273","DOI":"10.1523\/JNEUROSCI.4893-04.2005","article-title":"Neuropeptide Y protects against methamphetamine-induced neuronal apoptosis in the mouse striatum","volume":"25","author":"Thiriet","year":"2005","journal-title":"J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb1515","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/embor.2008.31","article-title":"Lentivector-mediated rescue from cerebellar ataxia in a mouse model of spinocerebellar ataxia","volume":"9","author":"Torashima","year":"2008","journal-title":"EMBO Rep"},{"key":"10.1016\/j.nbd.2016.07.022_bb1520","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nut.2003.10.007","article-title":"Assessment of the nutrition status of patients with Huntington's disease","volume":"20","author":"Trejo","year":"2004","journal-title":"Nutrition"},{"key":"10.1016\/j.nbd.2016.07.022_bb1525","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1460-9568.2003.02725.x","article-title":"Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors","volume":"18","author":"Tschenett","year":"2003","journal-title":"Eur. J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb1530","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1212\/WNL.46.6.1551","article-title":"Amantadine treatment is an independent predictor of improved survival in Parkinson's disease","volume":"46","author":"Uitti","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2016.07.022_bb1535","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.194","article-title":"Dopamine protects neurons against glutamate-induced excitotoxicity","volume":"4","author":"Vaarmann","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.nbd.2016.07.022_bb1540","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nn1226","article-title":"Orexigen-sensitive NPY\/AgRP pacemaker neurons in the hypothalamic arcuate nucleus","volume":"7","author":"van den Top","year":"2004","journal-title":"Nat. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb1545","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.parkreldis.2011.10.016","article-title":"Body mass index in Parkinson's disease: a meta-analysis","volume":"18","author":"van der Marck","year":"2012","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2016.07.022_bb1550","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0197-4580(02)00090-8","article-title":"Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease","volume":"24","author":"Vehmas","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2016.07.022_bb1555","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2193-1801-4-S1-P52","article-title":"Allosteric modulation of peptide ligand binding to neuropeptide Y receptor Y1 revealed by fluorescence-based assay","volume":"4","author":"Veiksina","year":"2015","journal-title":"SpringerPlus"},{"key":"10.1016\/j.nbd.2016.07.022_bb1560","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0920-1211(96)00059-9","article-title":"Functional changes in somatostatin and neuropeptide Y containing neurons in the rat hippocampus in chronic models of limbic seizures","volume":"26","author":"Vezzani","year":"1996","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb1565","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb1570","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0304-3940(89)90667-8","article-title":"Ultrastructural correlates of functional relationships between nigral dopaminergic or cortical afferent fibers and neuropeptide Y-containing neurons in the rat striatum","volume":"100","author":"Vuillet","year":"1989","journal-title":"Neurosci. Lett"},{"key":"10.1016\/j.nbd.2016.07.022_bb1575","doi-asserted-by":"crossref","DOI":"10.1111\/jnc.13624","article-title":"Neuropeptide Y (NPY) in cerebrospinal fluid from patients with Huntington's disease: increased NPY levels and differential degradation of the NPY fragment","author":"Wagner","year":"2016","journal-title":"J. Neurochem"},{"key":"10.1016\/j.nbd.2016.07.022_bb1580","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1124\/jpet.108.144634","article-title":"The novel neuropeptide Y Y5 receptor antagonist Lu AA33810 [N-[[trans-4-[(4,5-dihydro[1]benzothiepino[5,4-d]thiazol-2-yl)amino]cyclohexyl]me thyl]-methanesulfonamide] exerts anxiolytic- and antidepressant-like effects in rat models of stress sensitivity","volume":"328","author":"Walker","year":"2009","journal-title":"J. Pharmacol. Exp. Ther"},{"key":"10.1016\/j.nbd.2016.07.022_bb1585","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1007\/s00415-004-0316-4","article-title":"Weight loss, nutritional status and physical activity in patients with Alzheimer's disease. A controlled study","volume":"251","author":"Wang","year":"2004","journal-title":"J. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb1590","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1532-5415.1998.tb04537.x","article-title":"The association of weight change in Alzheimer's disease with severity of disease and mortality: a longitudinal analysis","volume":"46","author":"White","year":"1998","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.nbd.2016.07.022_bb1595","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1532-5415.1997.tb05187.x","article-title":"A longitudinal analysis of weight change in Alzheimer's disease","volume":"45","author":"White","year":"1997","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.nbd.2016.07.022_bb1600","doi-asserted-by":"crossref","first-page":"a021287","DOI":"10.1101\/cshperspect.a021287","article-title":"Adult neurogenesis in neurodegenerative diseases","volume":"7","author":"Winner","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol"},{"key":"10.1016\/j.nbd.2016.07.022_bb1605","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1073\/pnas.0404712102","article-title":"Transcellular induction of neuropeptide Y expression by NT4 and BDNF","volume":"102","author":"Wirth","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.07.022_bb1610","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cne.10823","article-title":"Comparative distribution of neuropeptide Y Y1 and Y5 receptors in the rat brain by using immunohistochemistry","volume":"464","author":"Wolak","year":"2003","journal-title":"J. Comp. Neurol"},{"key":"10.1016\/j.nbd.2016.07.022_bb1615","doi-asserted-by":"crossref","first-page":"a006734","DOI":"10.1101\/cshperspect.a006734","article-title":"Integration of clearance mechanisms: the proteasome and autophagy","volume":"2","author":"Wong","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol"},{"key":"10.1016\/j.nbd.2016.07.022_bb1620","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bbi.2010.09.006","article-title":"Running exercise protects the substantia nigra dopaminergic neurons against inflammation-induced degeneration via the activation of BDNF signaling pathway","volume":"25","author":"Wu","year":"2011","journal-title":"Brain Behav. Immun"},{"key":"10.1016\/j.nbd.2016.07.022_bb1625","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1745-7254.2005.00011.x","article-title":"Neuropeptide Y expression in mouse hippocampus and its role in neuronal excitotoxicity","volume":"26","author":"Wu","year":"2005","journal-title":"Acta Pharmacol. Sin"},{"key":"10.1016\/j.nbd.2016.07.022_bb1630","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1523\/JNEUROSCI.1637-10.2010","article-title":"BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice","volume":"30","author":"Xie","year":"2010","journal-title":"J. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb1635","first-page":"346","article-title":"Measurement of lumbar CSF levels of met-enkephalin, encrypted met-enkephalin, and neuropeptide Y in normal patients and in patients with Parkinson's disease before and after autologous transplantation of adrenal medulla into the caudate nucleus","volume":"115","author":"Yaksh","year":"1990","journal-title":"J. Lab. Clin. Med"},{"key":"10.1016\/j.nbd.2016.07.022_bb1640","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.brainres.2012.09.013","article-title":"Modulation of methamphetamine-induced nitric oxide production by neuropeptide Y in the murine striatum","volume":"1483","author":"Yarosh","year":"2012","journal-title":"Brain Res"},{"key":"10.1016\/j.nbd.2016.07.022_bb1645","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.mcn.2003.11.014","article-title":"Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease","volume":"25","author":"Zeron","year":"2004","journal-title":"Mol. Cell. Neurosci"},{"key":"10.1016\/j.nbd.2016.07.022_bb1650","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.cell.2008.01.033","article-title":"Mechanisms and functional implications of adult neurogenesis","volume":"132","author":"Zhao","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2016.07.022_bb1655","doi-asserted-by":"crossref","first-page":"7925","DOI":"10.1073\/pnas.1131955100","article-title":"Evidence for neurogenesis in the adult mammalian substantia nigra","volume":"100","author":"Zhao","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996116301802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996116301802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T19:34:25Z","timestamp":1772048065000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996116301802"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":332,"alternative-id":["S0969996116301802"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2016.07.022","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropeptide Y (NPY) as a therapeutic target for neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2016.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}